Compare CRNT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNT | SRZN |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 210.3M |
| IPO Year | 2000 | N/A |
| Metric | CRNT | SRZN |
|---|---|---|
| Price | $2.26 | $26.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 406.9K | 78.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.91 | N/A |
| Revenue Next Year | $6.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $7.11 |
| 52 Week High | $2.84 | $29.60 |
| Indicator | CRNT | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 52.92 |
| Support Level | $2.24 | $23.63 |
| Resistance Level | $2.43 | $27.96 |
| Average True Range (ATR) | 0.10 | 2.28 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 66.10 | 40.94 |
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).